WHO ARE WE ?
In the context of onchocerciasis control, Serious Side Effects (SSEs) have been observed after treatment with ivermectin (Mectizan®) in areas where loasis is co-endemic. This is how ISM was born in 2005, whose best known name is CRFilMT.
Our ambition is to contribute to the resolution of health problems through applied scientific research as well as to develop a system of monitoring, prevention and management of serious side effects occurring after mass treatment campaigns with ivermectin (Mectizan®) for onchocerciasis among others.